COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean

Virtual Health Sciences Library

  • Home
  • Search
  • Knowledge Base
  • Get a journal indexed in the Index Medicus
  • MyVHSL
  1. Home
  2. IMEMR
  3. Search Result
  4. New perspectives in the management of hypertension: role of herbal medicines

New perspectives in the management of hypertension: role of herbal medicines

Authors

Turab Syed Mohsin
Rookh, Mahay
Amber
Khan, Usman Ghani
Bin Rehman, Asif
Jamali, Shah Nawaz
HamdardUniversity ; , Hamdard College of Medicine and Dentistry ; , Pharmacology and Therapeutics ;

Med. Forum Mon. 2015; 26 (2): 3-7
Medical Forum Monthly
Journal Country: Pakistan
P-ISSN: 1029-385X
Type of Publication: Journal Article
Category: Humans, Male, Female,
Type of Research: Clinical
Keywords: Hypertension / Drug Therapy
Board Subjects: Noncommunicable Diseases, Herbal Medicine ,Disease Management ,Losartan ,Diabetes Mellitus, Type 2 ,Angiotensin Receptor Antagonists ,Case-Control Studies
Citation: Syed Mohsin Turab ,Mahay Rookh ,Amber ,Usman Ghani Khan ,Asif Bin Rehman ,Shah Nawaz Jamali , New perspectives in the management of hypertension: role of herbal medicines, Med. Forum Mon. 2015; 26 (2): 3-7

Abstract English

To compare the efficacy of coded herbal medicine [Hyprol] and losartan in hypertensive type II diabetic patients. Case control study. This study was carried out at the Out-patient Department of JPMC, Karachi and Herbal Clinics of Karachi from January 2014 to June 2014. This study is a case control prospective study to compare the effects of Losartan with herbal medicine [Hyprol] in type 2 diabetic hypertensive patients.200 patients were enrolled and divided in two groups [A] [Control group] and [B] [Test group] treated with Losartan and Hyprol respectively. With ARB [Losartan] baseline to final change for SBP as well as DBP was significantly reduced i. e.22.45% [p<0.001] and 16.84% [p<0.001] respectively and FBS was reduced by 21.85% [p<0.001] while Hyprol shows comparable results i. e. difference in SBP, DBP and FBS was 14% [p<0.001] , 15.31% [p<0.001] , 34.57% [p<0.001] respectively. ARBs are the first line drug of choice for hypertension since long time. Use of herbal medicine is an alternative mean of therapy to treat these patients and limit its cardiovascular and renal complications

Request full text

Subscribe to VHSL Newsletters

© 2020 WHO – EMRO